Graft

(redirected from Graft rejection)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to Graft rejection: Graft versus host disease

Graft

An informal term for bribery.
References in periodicals archive ?
We are very encouraged by these results as they represent real progress in the development of GS-101 as a new treatment to combat corneal graft rejection," explained Dr.
Mickie Bhatia of the Robarts Research Institute in London, Ontario and scientists at Geron demonstrate that undifferentiated hESCs transplanted in vivo, unlike other human cells, do not elicit certain immune responses that normally trigger graft rejection.
The drug Neoral (cyclosporine for microemulsion) is one of the mainstays of immunosuppression in transplant patients, permitting long-term survival, but the risk of acute and chronic graft rejection persists.
In Sweden, 50% of patients awaiting kidney transplants have high HLA antibody levels in their blood, which places them at high risk for graft rejection.
XenoTrans now has the technology to rapidly test the multiple genes required to inhibit graft rejection and produce the optimal pig for transplantation," stated Dr.
The second and third procedures were done because of previous graft rejection.
Results from clinical studies that have followed more than 1,500 heart and kidney transplant recipients for up to 36 months showed that Certican, when administered concurrently with Neoral(R) (cyclosporine USP) MODIFIED and corticosteroids, effectively prevented graft rejection.
During the study period, a female renal transplant recipient whose graft was obtained from a female organ donor was admitted with a clinical diagnosis of acute graft rejection.
Indeed, they say, rationally designed peptides could in theory either act as vaccines or, in the case of immune-suppressing peptides, be useful as therapies for autoimmune diseases or to suppress graft rejection.
Treatment with sCD83 achieved kidney graft tolerance in the complete absence of anti-donor antibodies; in contrast, untreated placebo recipients demonstrated severe graft rejection.
Washington, Mar 4 (ANI): The experimental drug belatacept are better than standard immunosuppressive drugs in preventing graft rejection in kidney transplant recipients and preserving kidney function, a new study claims.